Analysis of the intraductal microenvironment for the early diagnosis of breast cancer: Identification of biomarkers in nipple-aspirate fluids

Expert Opinion on Medical Diagnostics

Volumn 2, Issue 11, 2008, Pages 1221-1231

  Mannello, Ferdinando ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Benign breast diseases; Biomarkers; Breast cancer; Breast microenvironment; Early diagnosis; Intraductal approach; Nipple aspirate fluid

Indexed keywords

ALBUMIN; ALPHA LACTALBUMIN; ANDROGEN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; CHITINASE; CHOLESTEROL; DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; FATTY ACID; GROWTH HORMONE; IMMUNOGLOBULIN; LACTOSE; LIPID; METALLOPROTEINASE; PHOSPHOLIPASE A2; PLASMINOGEN ACTIVATOR; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; STEROID; TESTOSTERONE; TRANSFORMING GROWTH FACTOR ALPHA;

ANEUPLOIDY; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; BIOCHEMISTRY; BREAST CANCER; BREAST DUCT; CANCER SCREENING; CELL METABOLISM; CELL STRUCTURE; CHROMOSOMAL INSTABILITY; CHROMOSOME REARRANGEMENT; CYTOPATHOLOGY; DNA DETERMINATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HETEROZYGOSITY LOSS; HUMAN; LAVAGE; MAMMOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL ASSESSMENT; MICROENVIRONMENT; NIPPLE ASPIRATION; NON INVASIVE MEASUREMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 60549087395     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2.11.1221     Document Type: Review

References (94)

1. Lester J. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies. Clin J Oncol Nurs 2007;11:619-22
2. Fabian CJ, Kimler BF, Mayo MS, et al. Breast-tissue sampling for risk assessment and prevention. Endocr Relat Cancer 2005;12:185-213
3. Sauter ER. Analysis of nipple aspirate fluid for diagnosis of breast cancer: an alternative to invasive biopsy. Expert Rev Mol Diagn 2005;5:873-81
4. Petrakis NL. Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid. Breast Cancer Res Treat 1986;8:7-19
5. Petrakis NL. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev 1993;2:3-10
6. Adair FE, Bagg HJ. Breast stasis as the cause of mammary cancer. Int Clin 1925;4:19-26
7. Sartorius OW. Breast fluid cells help in early cancer detection. JAMA 1973;224:823-7
8. Petrakis NL, Mason L, Lee R, et al. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration. J Natl Cancer Inst 1975;54:829-34
9. Mannello F, Tonti GA, Papa S. Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies. Breast Cancer Res Treat 2006;97:115-29
10. Sauter ER, Ross E, Daly M, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 1997;76:494-501
11. Malatesta M, Mannello F, Bianchi G, et al. Biochemical and ultrastructural features of human milk and nipple aspirate fluids. J Clin Lab Anal 2000;14:330-5
12. Petrakis NL. Nipple aspirate fluid in epidemiologic studies of breast disease. Epidemiol Rev 1993;15:188-95
13. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996;5:785-94
14. Sauter ER, Winn JN, Dale PS, et al. Nipple aspirate fluid color is associated with breast cancer. Cancer Detect Prev 2006;30:322-8
15. Dua RS, Isacke CM, Gui GP. The intraductal approach to breast cancer biomarker discovery. J Clin Oncol 2006;24:1209-16
16. Mannello F, Tonti GA, Canestrari F. Nutrients and nipple aspirate fluid composition: the breast microenvironment regulates protein expression and cancer aetiology. Genes Nutr 2008;3:77-85
17. Wrensch MR, Petrakis NL, Gruenke LD, et al. Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat 1990;15:39-51
18. Zhang L, Shao ZM, Beatty P, et al. The use of oxytocin in nipple fluid aspiration. Breast J 2003;9:266-8
19. Suijkerbuijk KP, van der WE, van Diest PJ. Oxytocin: bringing magic into nipple aspiration. Ann Oncol 2007;18:1743-4
20. Papanicolaou GN, Holmquist DG, Bader GM, Falk EA. Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer 1958;11:377-409
21. Petrakis NL, Mason L, Lee R, et al. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration. J Natl Cancer Inst 1975;54:829-34
22. King EB, Chew KL, Petrakis NL, et al. Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst 1983;71:1115-21
23. King EB, Kromhout LK, Chew KL, et al. Analytic studies of foam cells from breast cancer precursors. Cytometry 1984;5:124-30
24. Tice JA, Miike R, Adduci K, et al. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population. Cancer Epidemiol Biomarkers Prev 2005;14:324-8
25. Buehring GC, Letscher A, McGirr KM, et al. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study. Breast Cancer Res Treat 2006;98:63-70
26. Mannello F, Tonti GA, Qin W, et al. Do nipple aspirate fluid epithelial cells and their morphology predict breast cancer development? Breast Cancer Res Treat 2007;102:125-7
27. Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992;135:130-41
28. King EB, Chew KL, Hom JD, et al. Multiple sampling for increasing the diagnostic sensitivity of nipple aspirate fluid for atypical cytology. Acta Cytol 2004;48:813-7
29. Krishnamurthy S, Sneige N, Thompson PA, et al. Nipple aspirate fluid cytology in breast carcinoma. Cancer 2003;99:97-104
30. Locke I, Mitchell G, Eeles R. Ductal approaches to assessment and management of women at high risk for developing breast cancer. Breast Cancer Res 2004;6:75-81
31. Mitchell G, Antill YC, Murray W, et al. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Res 2005;7:R1122-31
32. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993;15:196-208
33. Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992;135:130-41
34. Baltzell KA, Moghadassi M, Rice T, et al. Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: a historic prospective study. BMC Cancer 2008;8:75
35. Mannello F, Tonti GA, Medda V, et al. Increased shedding of soluble fragments of p-cadherin in nipple aspirate fluids from women with breast cancer. Cancer Sci 2008 Sep 22. [Epub ahead of print] doi: 10.1111/ j.1349-7006.2008.00921.x
36. Sauter ER, Ehya H, Babb J, et al. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer 1999;81:1222-7
37. Isaacs C, Cavalli LR, Cohen Y, et al. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients. Breast Cancer Res Treat 2004;84:99-105
38. Zhu W, Qin W, Ehya H, et al. Microsatellite changes in nipple aspirate fluid and breast tissue from women with breast carcinoma or its precursors. Clin Cancer Res 2003;9:3029-33
39. Krassenstein R, Sauter E, Dulaimi E, et al. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res 2004;10:28-32
40. Losanoff JE, Zhu W, Qin W, et al. Can mitochondrial DNA mutations in circulating white blood cells and serum be used to detect breast cancer? Breast 2008;17:540-2
41. Sanchez LM, Vizoso F, ez-Itza I, et al. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res 1992;52:95-100
42. Petrakis NL, Doherty M, Lee R, et al. Immunoglobulin levels in breast fluids of women with breast cancer. Clin Immunol Immunopathol 1977;7:386-93
43. Mannello F, Qin W, Zhu W, et al. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2. Breast Cancer Res Treat 2008;111:209-18
44. Lithgow D, Nyamathi A, Elashoff D, et al. C-reactive protein in nipple aspirate fluid associated with Gail model factors. Biol Res Nurs 2007;9:108-16
45. Qin W, Zhu W, Schlatter L, et al. Increased expression of the inflammatory protein YKL-40 in precancers of the breast. Int J Cancer 2007;121:1536-42
46. Sauter ER, Daly M, Linahan K, et al. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:967-70
47. Mannello F, Malatesta M, Sebastiani M, et al. Molecular forms and ultrastructural localization of prostate-specific antigen in nipple aspirate fluids. Clin Chem 1999;45:2263-6
48. Zhao Y, Verselis SJ, Klar N, et al. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts. J Clin Oncol 2001;19:1462-7
49. Phillips HA, Howard GC, Miller WR. Pilot studies on the p53 gene in nipple aspirate fluid from patients with breast cancer. Breast Cancer Res Treat 2000;61:139-43
50. Motomura K, Koyama H, Noguchi S, et al. Detection of c-erbB-2 gene amplification in nipple discharge by means of polymerase chain reaction. Breast Cancer Res Treat 1995;33:89-92
51. Qin W, Zhu W, Wagner-Mann C, et al. Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. Ann Surg Oncol 2003;10:948-53
52. Mannello F, Sebastiani M. Zymographic analyses and measurement of matrix metalloproteinase-2 and -9 in nipple aspirate fluids. Clin Chem 2003;49:1546-50
53. Wynder EL, Hill P. Prolactin, oestrogen, and lipids in breast fluid. Lancet 1977;2:840-2
54. Petrakis NL, Lim ML, Miike R, et al. Nipple aspirate fluids in adult nonlactating women-lactose content, cationic Na+, K+, Na+/K+ ratio, and coloration. Breast Cancer Res Treat 1989;13:71-8
55. Petrakis NL, Gruenke LD, Craig JC. Cholesterol and cholesterol epoxides in nipple aspirates of human breast fluid. Cancer Res 1981;41:2563-5
56. Gruenke LD, Craig JC, Petrakis NL, et al. Analysis of cholesterol, cholesterol-5, 6-epoxides and cholestane-3 beta,5 alpha, 6 beta-triol in nipple aspirates of human breast fluid by gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom 1987;14:335-8
57. Mannello F, Tonti GA, Pagliarani S, et al. The 8-epimer of prostaglandin F(2alpha), a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer. Int J Cancer 2007;120:1971-6
58. Kumar SR, Sauter ER, Quinn TP, et al. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection. Clin Cancer Res 2005;11:6868-71
59. Rose DP. Hormones in breast fluid. Breast Cancer Res Treat 1986;8:25-8
60. Rose DP. Hormones and growth factors in nipple aspirates from normal women and benign breast disease patients. Cancer Detect Prev 1992;16:43-51
61. Chatterton RT Jr, Geiger AS, Mateo ET, et al. Comparison of hormone levels in nipple aspirate fluid of pre- and postmenopausal women: effect of oral contraceptives and hormone replacement. J Clin Endocrinol Metab 2005;90:1686-91
62. Gann PH, Geiger AS, Helenowski IB, et al. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol Biomarkers Prev 2006;15:39-44
63. Hsiung R, Zhu W, Klein G, et al. High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer. Cancer J 2002;8:303-10
64. Sauter ER, Wagner-Mann C, Ehya H, et al. Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. Cancer Detect Prev 2007;31:50-8
65. Hill P, Wynder EL. Nicotine and continine in breast fluid. Cancer Lett 1979;6:251-4
66. Kato I, Ren J, Visscher DW, et al. Nutritional predictors for cellular nipple aspirate fluid: Nutrition and Breast Health Study. Breast Cancer Res Treat 2006;97:33-9
67. LaKind JS, Wilkins AA, Bates MN. Human breast biomonitoring and environmental chemicals: use of breast tissues and fluids in breast cancer etiologic research. J Expo Sci Environ Epidemiol 2007;17:525-40
68. Klein P, Glaser E, Grogan L, et al. Biomarker assays in nipple aspirate fluid. Breast J 2001;7:378-87
69. Rose DP, Berke B, Cohen LA, et al. A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease. Cancer 1987;60:2761-5
70. Ernster VL, Wrensch MR, Petrakis NL, et al. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst 1987;79:949-60
71. Petrakis NL, Wrensch MR, Ernster VL, et al. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 1987;40:587-91
72. Sauter ER, Garofalo C, Hewett J, et al. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer. Horm Metab Res 2004;36:336-40
73. Mannello F, Fabbri L, Ciandrini E, et al. Increased levels of erythropoietin in nipple aspirate fluid and in ductal cells from breast cancer patients. Cell Oncol 2008;30:51-61
74. Connolly JM, Rose DP. Epidermal growth factor-like proteins in breast fluid and human milk. Life Sci 1988;42:1751-6
75. Liu Y, Wang JL, Chang H, et al. Breast-cancer diagnosis with nipple fluid bFGF. Lancet 2000;356:567
76. Sauter ER, Chervoneva I, Diamandis A, et al. Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer. Cancer Detect Prev 2002;26:149-157
77. Shao ZM, Liu Y, Nguyen M. The role of the breast ductal system in the diagnosis of cancer [review]. Oncol Rep 2001;8:153-6
78. Sauter ER, Diamandis EP. Prostate-specific antigen levels in nipple aspirate fluid. J Clin Oncol 2001;19:3160
79. Mannello F, Gazzanelli G. Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics? Breast Cancer Res 2001;3:238-43
80. Foretova L, Garber JE, Sadowsky NL, et al. Carcinoembryonic antigen in breast nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev 1998;7:195-8
81. Kahana L, Bartal AH, Yechieli H, et al. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women. Isr J Med Sci 1981;17:1035-40
82. Koutselini H, Malliri A, Field JK, et al. p53 expression in cytologic specimens from benign and malignant breast lesions. Anticancer Res 1991;11:1415-9
83. Inaji H, Koyama H, Motomura K, et al. ErbB-2 protein levels in nipple discharge: role in diagnosis of early breast cancer. Tumour Biol 1993;14:271-8
84. Kuerer HM, Thompson PA, Krishnamurthy S, et al. High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res 2003;9:601-5
85. Gruenke LD, Wrensch MR, Petrakis NL, et al. Breast fluid cholesterol and cholesterol epoxides: relationship to breast cancer risk factors and other characteristics. Cancer Res 1987;47:5483-7
86. Paweletz CP, Trock B, Pennanen M, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers 2001;17:301-7
87. Varnum SM, Covington CC, Woodbury RL, et al. Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer. Breast Cancer Res Treat 2003;80:87-97
88. Alexander H, Stegner AL, Wagner-Mann C, et al. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 2004;10:7500-10
89. Sauter ER, Zhu W, Fan XJ, et al. Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br J Cancer 2002;86:1440-3
90. Coombes KR, Fritsche HA Jr, Clarke C, et al. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin Chem 2003;49:1615-23
91. Saucer ER, Shan S, Hewett JE, et al. Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int J Cancer 2005;114:791-6
92. Pawlik TM, Fritsche H, Coombes KR, et al. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 2005;89:149-57
93. Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 2001;93:1791-8
94. Zalles CM, Kimler BF, Simonsen M, et al. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat 2006;97:191-7